“263”的搜索结果

6 个项目

每页

设置降序顺序
  1. Mutated EGFR-IN-2

    Catalog No. A18565
    Quick View
    EGFR 抑制剂
    Mutated EGFR-IN-2 (compound 91) is a mutant-selective EGFR inhibitor extracted from patent WO2017036263A1, which potently inhibits single-mutant EGFR (T790M) and double-mutant EGFR (including L858R/T790M (IC50=??1nM) and ex19del/T790M), and can suppress activity of single gain-of-function mutant EGFR (including L858R and ex19del) as well. Mutated EGFR-IN-2 shows anti-tumor antivity. 了解更多
  2. ARRY-380 (Irbinitinib)

    Catalog No. A16413
    Quick View
    HER2 抑制剂
    ARRY-380是人表皮生长因子受体酪氨酸激酶ErbB-2(也称为HER2)的口服生物利用抑制剂,具有潜在的抗肿瘤活性。 了解更多
  3. QL47

    Catalog No. A16263
    Quick View
    BTK 抑制剂
    QL47是一种有效,选择性和不可逆的BTK激酶抑制剂,IC50为7 nM。 了解更多
  4. AZD3759

    Catalog No. A15551
    Quick View
    EGFR 抑制剂
    AZD3759是表皮生长因子受体(EGFR)的口服抑制剂。它结合并抑制EGFR以及某些突变形式的EGFR的活性。 了解更多
  5. Toceranib phosphate

    Catalog No. A15263
    Quick View
    Toceranib phosphate是通过抑制KIT,血管内皮生长因子受体2和PDGFRβ而具有抗肿瘤和抗血管生成活性的激酶抑制剂。 了解更多
  6. BMS-690514

    Catalog No. A11263
    Quick View
    VEGFR/EGFR 抑制剂
    BMS-690514是一种有效的选择性表皮生长因子受体(EGFR),HER2和HER4抑制剂,以及VEGF受体激酶。 了解更多

6 个项目

每页

设置降序顺序
Rewards